Horizon Discovery Raises Additional $10.5M in Series C Financing Round | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery today announced a £6.9 million ($10.5 million) final closing to its Series C funding round, bringing the total raised in the round to £18.2 million.

The closing of the round, the Cambridge, UK-based life science research tools firm said, will enable it to transition from a three-year investment phase to an organic growth phase "that it forecasts will deliver sustainable profit" from the second half of this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.